E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/18/2012 in the Prospect News High Yield Daily and Prospect News Liability Management Daily.

Biomet offers to buy back 10% notes, up to $500 million 11 5/8% notes

By Angela McDaniels

Tacoma, Wash., Sept. 18 - Biomet, Inc. began a tender offer for any and all of its 10% senior notes due 2017 and up to $500 million of its outstanding 11 5/8% senior subordinated notes due 2017, according to a company news release.

The tender offer will expire at midnight ET on Oct. 16.

The purchase price per $1,000 principal amount of notes is $1,055.50 for the 10% notes and $1,064.63 for the 11 5/8% notes. These prices include a $30.00 early tender premium for each note tendered by 5 p.m. ET on Oct. 1, the early tender time.

The company will also pay accrued interest up to but excluding the payment date.

If holders validly tender more than $500 million principal amount of 11 5/8% notes, then Biomet will accept tendered 11 5/8% notes for purchase on a prorated basis.

Notes may be tendered and accepted for payment only in principal amounts equal to $2,000 and integral multiples of $1,000 in excess thereof.

Biomet intends to redeem any 10% notes that remain outstanding after the offer at a redemption price equal to $1,050.00 per $1,000 principal amount of notes.

The company will also redeem an amount of 11 5/85 notes equal to $500 million minus the amount accepted for payment in the tender offer. The redemption price will be $1,058.13 per $1,000 principal amount of notes.

The tender offer is conditioned on the completion of an offering of notes. The company plans to price $825 million principal amount of 6½% senior notes due 2020 and $500 million principal amount of senior subordinated notes due 2020.

The dealer managers are Goldman Sachs & Co. (800 828-3182 or 212 357-0345) and Bank of America Merrill Lynch (888 292-0070 or 980 387-3907). The depositary and information agent is Global Bondholder Services Corp. (866 807-2200).

Biomet makes products used by musculoskeletal medical specialists. The company is based in Warsaw, Ind.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.